These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29205077)

  • 1. Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration.
    Ejlertsen B; Offersen BV; Overgaard J; Christiansen P; Jensen MB; Kroman N; Knoop AS; Mouridsen H
    Acta Oncol; 2018 Jan; 57(1):3-12. PubMed ID: 29205077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trial.
    Overgaard M; Nielsen HM; Tramm T; Højris I; Grantzau TL; Alsner J; Offersen BV; Overgaard J;
    Radiother Oncol; 2022 May; 170():4-13. PubMed ID: 35288227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy - results from two independent randomized trials.
    Laurberg T; Tramm T; Nielsen T; Alsner J; Nord S; Myhre S; Sørlie T; Leung S; Fan C; Perou C; Gelmon K; Overgaard J; Voduc D; Prat A; Cheang MCU
    Acta Oncol; 2018 Jan; 57(1):38-43. PubMed ID: 29172851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007-2016.
    Jensen MB; Laenkholm AV; Offersen BV; Christiansen P; Kroman N; Mouridsen HT; Ejlertsen B
    Acta Oncol; 2018 Jan; 57(1):13-18. PubMed ID: 29202621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.
    Overgaard M; Jensen MB; Overgaard J; Hansen PS; Rose C; Andersson M; Kamby C; Kjaer M; Gadeberg CC; Rasmussen BB; Blichert-Toft M; Mouridsen HT
    Lancet; 1999 May; 353(9165):1641-8. PubMed ID: 10335782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials.
    Overgaard M; Nielsen HM; Overgaard J
    Radiother Oncol; 2007 Mar; 82(3):247-53. PubMed ID: 17306393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the prognostic and predictive value of the intrinsic subtypes and a validated gene profile predictive of loco-regional control and benefit from post-mastectomy radiotherapy in patients with high-risk breast cancer.
    Tramm T; Kyndi M; Myhre S; Nord S; Alsner J; Sørensen FB; Sørlie T; Overgaard J
    Acta Oncol; 2014 Oct; 53(10):1337-46. PubMed ID: 24957550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.
    ; Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
    J Clin Oncol; 2006 May; 24(15):2268-75. PubMed ID: 16618947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmastectomy irradiation in high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group trials.
    Overgaard M; Christensen JJ; Johansen H; Nybo-Rasmussen A; Brincker H; van der Kooy P; Frederiksen PL; Laursen F; Panduro J; Sørensen NE
    Acta Oncol; 1988; 27(6A):707-14. PubMed ID: 3064776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link.
    Van de Steene J; Soete G; Storme G
    Radiother Oncol; 2000 Jun; 55(3):263-72. PubMed ID: 10869741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial.
    Knoop AS; Lænkholm AV; Jensen MB; Nielsen KV; Andersen J; Nielsen D; Ejlertsen B;
    Eur J Cancer; 2014 May; 50(8):1412-21. PubMed ID: 24675287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c.
    Kyndi M; Overgaard M; Nielsen HM; Sørensen FB; Knudsen H; Overgaard J
    Radiother Oncol; 2009 Jan; 90(1):74-9. PubMed ID: 18471914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up.
    Avril A; Le Bouëdec G; Lorimier G; Classe JM; Tunon-de-Lara C; Giard S; MacGrogan G; Debled M; Mathoulin-Pélissier S; Mauriac L;
    Eur J Surg Oncol; 2011 Jul; 37(7):563-70. PubMed ID: 21665421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant chemotherapy of early stage breast cancer].
    Boér K
    Orv Hetil; 2010 Feb; 151(9):344-53. PubMed ID: 20159750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local recurrence of breast cancer after mastectomy and modern multidisciplinary treatment.
    Siponen ET; Joensuu H; Leidenius MH
    Acta Oncol; 2013 Jan; 52(1):66-72. PubMed ID: 22971019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current status of treatment for early-stage invasive breast cancer].
    Kásler M; Polgár C; Fodor J
    Orv Hetil; 2009 May; 150(22):1013-21. PubMed ID: 19465349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
    J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure pattern and survival after breast conserving therapy. Long-term results of the Danish Breast Cancer Group (DBCG) 89 TM cohort.
    Lyngholm CD; Laurberg T; Alsner J; Damsgaard TE; Overgaard J; Christiansen PM
    Acta Oncol; 2016 Aug; 55(8):983-92. PubMed ID: 27120011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assurance of conventional non-CT-based internal mammary lymph node irradiation in a prospective Danish Breast Cancer Cooperative Group trial: the DBCG-IMN study.
    Thorsen LB; Thomsen MS; Overgaard M; Overgaard J; Offersen BV;
    Acta Oncol; 2013 Oct; 52(7):1526-34. PubMed ID: 23957621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.